parapsoriasis
Information
- Disease name
- parapsoriasis
- Disease ID
- DOID:9088
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00106847 | Completed | Phase 3 | A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis | January 2003 | July 2005 |
| NCT02330237 | Completed | Phase 2/Phase 3 | Natural Gels for Treatment of Plaque Psoriasis | January 2015 | September 2017 |
| NCT02425826 | Completed | Phase 4 | A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis. | April 20, 2015 | November 22, 2016 |
| NCT00322296 | Terminated | Phase 2 | Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis | April 2001 | August 2004 |
| NCT02502188 | Terminated | Phase 1 | Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis | July 17, 2015 | November 2, 2015 |
- Disase is a (Disease Ontology)
- DOID:8893
- Cross Reference ID (Disease Ontology)
- GARD:7328
- Cross Reference ID (Disease Ontology)
- ICD10CM:L41
- Cross Reference ID (Disease Ontology)
- ICD9CM:696.2
- Cross Reference ID (Disease Ontology)
- MESH:D010267
- Cross Reference ID (Disease Ontology)
- NCI:C3312
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:267851002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0030491
- ICD10 preferred id (Insert disease from ICD10)
- D0009759
- ICD10 class code (Insert disease from ICD10)
- L41
- MeSH unique ID (MeSH (Medical Subject Headings))
- D010267